Original Creatine Patent Co. v. Met-Rx USA, Inc.

387 F. Supp. 2d 564, 2005 U.S. Dist. LEXIS 7894, 2005 WL 1048748
CourtDistrict Court, E.D. Virginia
DecidedMay 3, 2005
DocketCiv.A. 204CV759
StatusPublished
Cited by10 cases

This text of 387 F. Supp. 2d 564 (Original Creatine Patent Co. v. Met-Rx USA, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Original Creatine Patent Co. v. Met-Rx USA, Inc., 387 F. Supp. 2d 564, 2005 U.S. Dist. LEXIS 7894, 2005 WL 1048748 (E.D. Va. 2005).

Opinion

MEMORANDUM OPINION AND ORDER

FRIEDMAN, District Judge.

This matter comes before the court on the motion of the defendant, MeNRx USA, Inc. d/b/a/ Met-Rx Engineered Nutrition (“MeNRx”), to transfer this action to the United States District Court for the Eastern District of New York, pursuant to 28 U.S.C. § 1404(a). For the reasons set forth herein, the defendant’s motion to transfer is GRANTED.

I. Factual and Procedural History

The plaintiff, The Original Creatine Patent Company, Ltd. (“OCPC”), filed a complaint on December 20, 2004, seeking relief for the defendant’s alleged willful induced patent infringement. The plaintiff is the assignee of the rights and title in United States Patent No. 5.769,159 (“the ’159 patent”), which concerns a method for optimizing creatine intake that is commonly referred to as “creatine loading.” Creatine is a chemical that is marketed and sold by the defendant as a sports nutrition product. Its use by weight lifters and other athletes is associated with increased body mass, strength, endurance and athletic performance.

The plaintiff is a British company organized under the laws of the United Kingdom with its principal place of business located in Cambridge, United Kingdom. The defendant is a Nevada corporation with its principal place of business in Bohemia, New York. 1 The defendant is a manufacturer, wholesaler and distributor of sports nutrition supplements and related food products, creatine among them, which it sells to independent retailers and distributors nationwide, including some retailers and one distributor in Virginia.

The defendant filed its motion to transfer this action on February 22, 2005. Fol *566 lowing two granted motions for extensions of time, which were also agreed to by the defendant, the plaintiff filed its opposition memorandum on April 1, 2005. Following the plaintiffs second motion for an extension of time, but prior to the order granting such extension, the Rule 16(b) scheduling conference was held and trial in this matter was set for October 18, 2005. The defendant filed its reply memorandum on April 6, 2005. Thus, the matter is fully briefed and ripe for judicial resolution.

II. Discussion

A. Standard of Review — Motion to Transfer

Title 28 U.S.C. § 1404(a) provides that “for the convenience of the parties and witnesses, in the interest of justice, a district court may transfer any civil action to any other district or division where it might have been brought.” The purpose of this section is “to prevent the waste of ‘time, energy and money’ and ‘to protect litigants, witnesses and the public against unnecessary inconvenience and expense.’ ” Van Dusen v. Barrack, 376 U.S. 612, 616, 84 S.Ct. 805, 11 L.Ed.2d 945 (1964) (quoting Continental Grain Co. v. Barge FBL-585, 364 U.S. 19, 26-27, 80 S.Ct. 1470, 4 L.Ed.2d 1540 (1960)). As the Supreme Court has explained, section 1404(a) “is intended to place discretion in the district court to adjudicate motions for transfer according to an ‘individualized, case-by-case consideration of convenience and fairness.’ ” Stewart Org., Inc. v. Ricoh, Corp., 487 U.S. 22, 29, 108 S.Ct. 2239, 101 L.Ed.2d 22 (1988) (citing Van Dusen v. Barrack, 376 U.S. 612, 622, 84 S.Ct. 805, 11 L.Ed.2d 945 (1964)); see also Cognitronics Imaging Sys., Inc. v. Recognition Research, Inc., 83 F.Supp.2d 689, 696 (E.D.Va.2000) (recognizing discretion placed in district court to transfer for more convenient forum). The burden is on the movant to show that a transfer under 28 U.S.C. § 1404(a) is warranted. See Cognitronics, 83 F.Supp.2d at 696.

In order to decide if a transfer of venue is appropriate in this matter, the court must first determine whether the suit could have been brought in the Eastern District of New York, and second, whether the balance of convenience to the parties and consideration of the interest of justice justify transfer to the Eastern District of New York. See LG Elecs., Inc. v. Asustek Computers, 126 F.Supp.2d 414, 423 (E.D.Va.2000); Corry v. CFM Majestic Inc., 16 F.Supp.2d 660, 663 (E.D.Va.1998). After a review of the record in this case, the court finds that this case could have been initiated in the Eastern District of New York and that the relevant authority, factual circumstances and considerations of fairness and convenience compels its transfer.

B. Jurisdiction and Venue in the Eastern District of New York

In ruling on a motion to transfer, the court first determines whether the plaintiff could have brought its claims in the Eastern District of New York. See Agilent Tech., Inc. v. Micromuse, Inc., 316 F.Supp.2d 322, 325 (E.D.Va.2004). This prerequisite is satisfied if the federal district court in the Eastern District of New York court would have jurisdiction over the subject matter of the action, if venue would be proper, and if the defendant would be amenable to process in that court. See Koh v. Microtek Int’l, Inc., 250 F.Supp.2d 627, 630 (E.D.Va.2003).

Venue as to patent infringement claims is governed by 28 U.S.C. § 1400(b), which instructs that “any civil action for patent infringement may be brought in the judicial district where the defendant resides, or where the defendant has commit *567 ted acts of infringement and has a regular and established place of business. 28 U.S.C. § 1400.” 2 A corporate defendant “shall be deemed to reside in any judicial district in which it is subject to personal jurisdiction at the time the action is commenced.” Cognitronics, 83 F.Supp.2d at 691. Thus, if personal jurisdiction may be exercised over the defendant in the Eastern District of New York, the prerequisites of section 1400(b) are also satisfied.

The defendant has averred by sworn declaration that its Bohemia, New York offices are its corporate headquarters and that relevant corporate documents, officers and employees with knowledge of the sales and labeling of its products reside in New York. As the plaintiffs claim involves an alleged violation of federal patent laws, the federal district court in the Eastern District of New York has federal question subject matter jurisdiction. See 28 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
387 F. Supp. 2d 564, 2005 U.S. Dist. LEXIS 7894, 2005 WL 1048748, Counsel Stack Legal Research, https://law.counselstack.com/opinion/original-creatine-patent-co-v-met-rx-usa-inc-vaed-2005.